Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | BMC Complementary and Alternative Medicine

Fig. 1

From: Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway

Fig. 1

The effects of triptolide on the viability of human umbilical vein endothelial cells (HUVECs). HUVECs were treated with triptolide (25, 50 or 100 nM) for the indicated times. Cell viability was determined by an MTT assay. Data are expressed as the mean ± standard error of the mean. *p < 0.05 and **p < 0.01, compared with the corresponding control group

Back to article page